Skip to content

Alg9 Associated Autosomal Dominant Polycystic Kidney Disease Cn305626

Published: July 22, 2026Updated: August 20, 2026

A genetic form of polycystic kidney disease caused by ALG9 gene mutations, leading to fluid-filled cysts in the kidneys. It is inherited in an autosomal dominant pattern. Management focuses on controlling blood pressure, slowing cyst growth, and treating kidney complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q63.9
ICD-11
LA00.0
Body system
renal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Changes in urination or swelling

(renal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Hypertension

(renal)

Polyuria

(renal)

Recurrent urinary tract infections

(renal)

Progressive renal insufficiency

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Renal disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Renal Function Serial Monitoring

Comprehensive monitoring of kidney function through estimated glomerular filtration rate, urinalysis, and blood pressure measurements. Imaging studies track cyst burden and structural changes over time.

monitoring
3

Tolvaptan for Cyst Growth

Vasopressin V2 receptor antagonist that slows kidney cyst growth in appropriate candidates. Requires regular liver function monitoring due to potential hepatotoxicity and careful patient selection.

medication

Additional treatment options

Cardiovascular Health Optimization

Heart-healthy lifestyle modifications including regular aerobic exercise, smoking cessation, and maintaining healthy weight. These interventions reduce cardiovascular risk associated with ADPKD.

lifestyle

Fluid Intake Management

Increased water intake may help suppress vasopressin and potentially slow cyst growth. Daily fluid goals are individualized based on kidney function and stage of disease.

dietary

End-Stage Renal Disease Management

Preparation for and management of kidney failure including dialysis access planning and kidney transplant evaluation. Transplant is the definitive treatment for ESRD in eligible candidates.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alg9 Associated Autosomal Dominant Polycystic Kidney Disease Cn305626?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Correa de Santos JC, Patel MK, Huang WL. Genetic Counseling in Autosomal Dominant Polycystic Kidney Disease: Focus on Rare Variants. Clin J Am Soc Nephrol. 2022.

review2022
2

Bergmann C, Guay-Woodford LM, Harris PC, et al. International Consensus Recommendations for the Diagnosis and Management of Polycystic Kidney Disease. Kidney Int. 2021.

guideline2021
3

Nakamura T, Oyama T, Fischer-Zirkler R, et al. Clinical Characterization of ALG9-Associated Autosomal Dominant Polycystic Kidney Disease: A Prospective Cohort Study. Nephrol Dial Transplant. 2023.

clinical_trial2023
4

Wilson JC, Okonkwo DO, Yamamoto K. Emerging Therapeutic Targets in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis. Am J Kidney Dis. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Alg9 Associated Autosomal Dominant Polycystic Kidney Disease Cn305626. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy